Alveron Pharma
PrivateLast Round
Seed
Dec 6, 2024
Total Funding Raised
$17.08M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alveron Pharma is a biotechnology company developing a unique coagulation platform technology with the world's first cyclodextrin-based anticoagulant reversal drug.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alveron Pharma Comparables
Compare Alveron Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pinwheel Therapeutics | 90% | |
| VarmX | 89% | |
| Bioxodes | 82% | |
Alveron Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 6, 2024 | ||||
| Debt | Oct 7, 2021 | ||||
| Series A Extension | Oct 7, 2021 | ||||
| Series A | May 16, 2019 |
Key People
Founding team and executive leadership
Alveron Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Waterman Ventures | Seed, Series A, Series A Extension |
| Thuja Capital | Seed, Series A Extension, Series A |
| Waterman Ventures | Seed, Series A |
| Oost NL | Seed, Series A, Series A Extension |
| East Netherlands Development Agency (Oost NL) | Seed, Series A |
| Broadview Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors grew 104% MoM, reaching 1.2K.
- Dec 6, 2024
$5.28M round led by Broadview Ventures
Alveron Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alveron Pharma's valuation, stock price, and market status.